Overview
- Researchers at Zhejiang University collected earwax samples from 209 participants in China and analyzed volatile organic compounds using gas chromatography–mass spectrometry.
- Four VOCs—ethylbenzene, 4-ethyltoluene, pentanal and 2-pentadecyl-1,3-dioxolane—were found at significantly different levels in Parkinson’s patients versus healthy controls.
- An artificial intelligence olfactory model trained on the VOC profiles distinguished Parkinson’s disease samples from non-PD samples with 94% accuracy.
- The non-invasive earwax screening could serve as a first-line tool for earlier diagnosis and timely intervention before motor symptoms emerge.
- Researchers plan to conduct multi-center trials across diverse populations and clinical settings to validate and generalize the findings.